Nicholas Imperato DO, MPH

Intravenous Buprenorphine Reversed Opioid-Induced Respiratory Depression Without Precipitating Withdrawal in Emergency Department Patients (new in #openaccess @JSADjournal 87/3) @NickImperato14 @Rutgers_NJMS @RWJEM @RutgersARC jsad.com/doi/full/10.15…

In “Alcohol Use Disorder in the Emergency Department,” Nicholas S. Imperato, DO, MPH, Christopher W. Meaden, MD, MS, and Howard A. Greller, MD outline approaches for screening AUD and discuss opportunities to initiate treatment: emresident.org/26n8tcv/ #EM #AUD #MedEd

Meet the incoming EMRA Health Policy Academy fellows! These residents are stepping into a year of advocacy, leadership training, & real-world policy impact. This is where passion meets action. Stay tuned to see what this cohort accomplishes in 2026! #HealthPolicy #Leadership

#FOAMtox #FOAMed #Perspectives emdocs.net/alcohol-use-di…

New in the Health Policy Journal Club, EMRA explores research highlighting how post-overdose prescriptions of MOUD remain uncommon and inequitable. Read the full analysis → bit.ly/4o1s8S5 @NickImperato14 @PolicyRx @VidyaEswaran #HealthPolicy #PolicyRx #OUD

Intravenous Buprenorphine Reversed Opioid-Induced Respiratory Depression Without Precipitating Withdrawal in Emergency Department Patients (just accepted in @JSADjournal) @NickImperato14 @Rutgers_NJMS @RWJEM @RutgersARC jsad.com/doi/abs/10.152…

Do you start NALTREXONE 💊 for your emergency dept patients to treat alcohol use disorder? Here's why you should: aliem.com/naltrexone-aud… Read this concise, evidence-based review by Drs. @NickImperato14 , Greller, and Meaden from @RutgersNJMS_EM

In a recent #HealthPolicy Journal Club article, a review of #insuranceclaims shows that the most vulnerable patients may be avoiding the doctor, even for non-avoidable reasons. Read the article: emra.org/emresident/art… Feat.@NickImperato14 @PolicyRx @vidyaeswaran @RachelSolnickMD

ToxCard: Nitrous Oxide Use in the ED by Nicholas S. Imperato #FOAMed #FOAMtox #FOAMus #FOAMped @EMhighAK @long_brit @MprizzleER emdocs.net/toxcard-nitrou… emdocs.net/toxcard-nitrou…

ToxCard: Tianeptine by Nicholas S. Imperato #FOAMed #FOAMtox #FOAMus #FOAMped @EMhighAK @long_brit @MprizzleER emdocs.net/tianeptine/ emdocs.net/tianeptine/

This thread can be read here: policyprescriptions.org/a-tale-of-two-…

This month, EMRA and the Policy Rx Health Policy Journal Club focus on the opioid epidemic. Nicholas Imperato and Dr. Vidya Eswaran authored the article "A Tale of Two Prescriptions." Read it here - ow.ly/uSbQ50LXUXv @PolicyRx @RealCedricDark @vidyaeswaran @NickImperato14

"The public health program has afforded me the tools to evaluate our health care system through a different lens." DO/MPH student @NickImperato14. @frasso_rosemary @PCOMeducation #meded #publichealth bit.ly/3PrFrtl

A study led by @megkreed examines the potential of a xylazine test strip from the perspective of the substance user. Co-authors DO/MPH student @NickImperato14, @drugpolicyctr, Alum Amanda Guth, & @RisingKristin @DrugAlcoholDep @frasso_rosemary bit.ly/3IqWDNv

Today in @phillyopinion, read Nicholas S. Imperato on buprenorphine, a lifesaving opioid-use disorder treatment. "If your loved one was struggling with addiction, wouldn’t you want to make it easier for them to get help?" inquirer.com/opinion/bupren…